1. Home
  2. KVHI vs INDP Comparison

KVHI vs INDP Comparison

Compare KVHI & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

N/A

Current Price

$7.59

Market Cap

136.4M

Sector

Technology

ML Signal

N/A

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

N/A

Current Price

$1.13

Market Cap

125.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KVHI
INDP
Founded
1978
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
136.4M
125.2M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
KVHI
INDP
Price
$7.59
$1.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
162.1K
833.7K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
N/A
EPS
0.04
N/A
Revenue
$9,622,000.00
N/A
Revenue This Year
$28.90
N/A
Revenue Next Year
$31.85
N/A
P/E Ratio
$188.00
N/A
Revenue Growth
3.82
N/A
52 Week Low
$5.09
$0.92
52 Week High
$13.00
$8.57

Technical Indicators

Market Signals
Indicator
KVHI
INDP
Relative Strength Index (RSI) 39.40 39.08
Support Level $7.32 $0.92
Resistance Level $7.67 $1.58
Average True Range (ATR) 0.32 0.18
MACD -0.00 0.06
Stochastic Oscillator 35.68 32.58

Price Performance

Historical Comparison
KVHI
INDP

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Share on Social Networks: